Literature DB >> 28299673

Roles of RUNX in Hypoxia-Induced Responses and Angiogenesis.

Sun Hee Lee1, Sarala Manandhar1, You Mie Lee2.   

Abstract

During the past two decades, Runt domain transcription factors (RUNX1, 2, and 3) have been investigated in regard to their function, structural elements, genetic variants, and roles in normal development and pathological conditions. The Runt family proteins are evolutionarily conserved from Drosophila to mammals, emphasizing their physiological importance. A hypoxic microenvironment caused by insufficient blood supply is frequently observed in developing organs, growing tumors, and tissues that become ischemic due to impairment or blockage of blood vessels. During embryonic development and tumor growth, hypoxia triggers a stress response that overcomes low-oxygen conditions by increasing erythropoiesis and angiogenesis and triggering metabolic changes. This review briefly introduces hypoxic conditions and cellular responses, as well as angiogenesis and its related signaling pathways, and then describes our current knowledge on the functions and molecular mechanisms of Runx family proteins in hypoxic responses, especially in angiogenesis.

Entities:  

Keywords:  Angiogenesis; HIF-1α; Hypoxia; RUNX1; RUNX2; RUNX3; VEGF

Mesh:

Substances:

Year:  2017        PMID: 28299673     DOI: 10.1007/978-981-10-3233-2_27

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  16 in total

1.  Adipose-derived stem cell-derived microvesicle-released miR-210 promoted proliferation, migration and invasion of endothelial cells by regulating RUNX3.

Authors:  Zeqi Zheng; Lijuan Liu; Yuliang Zhan; Songping Yu; Ting Kang
Journal:  Cell Cycle       Date:  2018-07-05       Impact factor: 4.534

Review 2.  HIF-1α in Osteoarthritis: From Pathogenesis to Therapeutic Implications.

Authors:  Chu-Yang Zeng; Xi-Feng Wang; Fu-Zhou Hua
Journal:  Front Pharmacol       Date:  2022-07-05       Impact factor: 5.988

3.  A RASSF1A-HIF1α loop drives Warburg effect in cancer and pulmonary hypertension.

Authors:  Swati Dabral; Christian Muecke; Chanil Valasarajan; Mario Schmoranzer; Astrid Wietelmann; Gregg L Semenza; Michael Meister; Thomas Muley; Tamina Seeger-Nukpezah; Christos Samakovlis; Norbert Weissmann; Friedrich Grimminger; Werner Seeger; Rajkumar Savai; Soni S Pullamsetti
Journal:  Nat Commun       Date:  2019-05-13       Impact factor: 14.919

4.  Cancer Stem Cells: Emergent Nature of Tumor Emergency.

Authors:  Yaroslav R Efremov; Anastasia S Proskurina; Ekaterina A Potter; Evgenia V Dolgova; Oksana V Efremova; Oleg S Taranov; Aleksandr A Ostanin; Elena R Chernykh; Nikolay A Kolchanov; Sergey S Bogachev
Journal:  Front Genet       Date:  2018-11-16       Impact factor: 4.599

Review 5.  Role of RUNX Family Transcription Factors in DNA Damage Response.

Authors:  Ann Sanoji Samarakkody; Nah-Young Shin; Alan B Cantor
Journal:  Mol Cells       Date:  2020-02-29       Impact factor: 5.034

Review 6.  Pathological angiogenesis and inflammation in tissues.

Authors:  Ji-Hak Jeong; Uttam Ojha; You Mie Lee
Journal:  Arch Pharm Res       Date:  2020-11-23       Impact factor: 4.946

7.  Viral replication of SARS-CoV-2 could be self-limitative - The role of the renin-angiotensin system on COVID-19 pathophysiology.

Authors:  Vinicius Novaes Rocha
Journal:  Med Hypotheses       Date:  2020-10-01       Impact factor: 1.538

8.  Effect of circular RNA, mmu_circ_0000296, on neuronal apoptosis in chronic cerebral ischaemia via the miR-194-5p/Runx3/Sirt1 axis.

Authors:  Keyu Huang; Chunqing Yang; Jian Zheng; Xiaobai Liu; Jie Liu; Dongfang Che; Yixue Xue; Ping An; Di Wang; Xuelei Ruan; Bo Yu
Journal:  Cell Death Discov       Date:  2021-05-29

9.  A miRNA signature predicts benefit from addition of hypoxia-modifying therapy to radiation treatment in invasive bladder cancer.

Authors:  Mairah T Khan; Joely J Irlam-Jones; Ronnie Rodrigues Pereira; Brian Lane; Helen R Valentine; Kai Aragaki; Lars Dyrskjøt; David J McConkey; Peter J Hoskin; Ananya Choudhury; Catharine M L West
Journal:  Br J Cancer       Date:  2021-04-12       Impact factor: 7.640

10.  RUNX1: an emerging therapeutic target for cardiovascular disease.

Authors:  Alexandra Riddell; Martin McBride; Thomas Braun; Stuart A Nicklin; Ewan Cameron; Christopher M Loughrey; Tamara P Martin
Journal:  Cardiovasc Res       Date:  2020-07-01       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.